Clinical Trial Update: Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Peking University | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN